ABBV vs MRNA: Which Is the Better Dividend Stock?
As of Nov 1, 2026, ABBV (AbbVie Inc.) screens as the stronger dividend stock, winning 3 of 4 head-to-head metrics. ABBV offers the higher yield at 2.35%, ABBV has the higher dividend-safety score.
Key facts: ABBV vs MRNA
Data as of · Source: SmarterDividends data
- As of Nov 1, 2026, AbbVie Inc. (ABBV) has the higher forward dividend yield at 2.35%, versus 0.00% for Moderna, Inc. (MRNA).
- By SmarterDividends' count as of Nov 1, 2026, ABBV has raised its dividend for 12 consecutive years and MRNA for 0.
Cite this page
SmarterDividends, "ABBV vs MRNA: Dividend Yield, Safety & Value Compared," updated Nov 1, 2026, https://smarterdividends.com/compare/abbv-vs-mrna
| Metric | ABBV | MRNA |
|---|---|---|
| Forward yield | 2.35% | 0.00% |
| Annual dividend | $6.92 | $0.00 |
| Payout ratio | 117% | 0% |
| Years of growth | 12 yr | 0 yr |
| 5-yr dividend growth | 6.8% | — |
| 5-yr total return | 156% | — |
| Dividend safety score | 80 (A) | — |
| Fair value estimate | $192.09 | — |
| Upside to fair value | -35% | — |
| Frequency | quarterly | — |
| Market cap | $521.5B | $88.5B |
| P/E ratio | 50.7 | — |
Higher yield
ABBV
2.35%
Safer dividend
ABBV
Grade A
Faster growth
ABBV
6.8%
ABBV vs MRNA — FAQ
Is ABBV or MRNA a better dividend stock?
On the data, ABBV wins more head-to-head categories (3 vs 1). ABBV offers the higher yield (2.35%), while ABBV has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.
Which has a higher dividend yield, ABBV or MRNA?
ABBV has the higher forward dividend yield at 2.35%, versus 0.00% for MRNA.
Is ABBV or MRNA safer?
Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.